Drugs / [11C]NNC-112
last change Oct 2025 re-read 2 minutes ago

[11C]NNC-112

Diagnostic / imaging agent

Investigated by
National Institute of Mental Health (NIMH)

Trials 1 · a red edge is where a trial was stopped

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00088517 Jul 2004 → Mar 2006 National Institute of Mental Health (NIMH) Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT03190954 Comparator Aug 2017 → Oct 2025 opiate dependence National Institute on Alcohol Abuse and Alcoholism (NIAAA) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as [11C]NNC-112 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00088517
1

NCT03190954

Modality Diagnostic / imaging agent “PET radioligand” NCT00088517
Route Intravenous “a catheter (small plastic tube) is placed into a vein in the subject's arm for injecting the tracer” NCT00088517